antineoplastic agent K 18

conjugate of human IGG and melphalan used in treatment of neoplasms

Also Known As:

antineoplastic agent K-18

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Carcinoma (Carcinomatosis) 05/01/1988 - "Selective accumulation of a new antineoplastic agent, K-18 (human immunoglobulin conjugated melphalan), in Ehrlich carcinoma transplanted in mice."

1.	Melphalan (Alkeran)
2.	Immunoglobulins (Immunoglobulin)